SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022 April 7, 2022
Brother International Corporation Honored With 5-Star Rating in the 2022 CRN Partner Program Guide March 29, 2022
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis March 28, 2022
Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference March 28, 2022
New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix’s RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy March 24, 2022
